EcoDrugPlus

Cyclin-Dependent Kinase 5

Ensembl ID : ENSDLAG00005025973
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSDLAG00005023361
Gene Symbol: CDK7
1 Cross references
219 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSDLAG00005033463
Gene Symbol: CYSLTR1
1 Cross references
177 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSDLAG00005011548
Gene Symbol: CDAB
2 Cross references
199 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSDLAG00005007508
Gene Symbol: CYP17A1
2 Cross references
211 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSDLAG00005024320
Gene Symbol: CYP19A1A
1 Cross references
252 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 4

Ensembl ID : ENSDLAG00005020750
Gene Symbol: CYP46A1.4
1 Cross references
259 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSDLAG00005010300
Gene Symbol: DGAT1A
1 Cross references
191 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSDLAG00005008165
Gene Symbol: DGAT1B
1 Cross references
187 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSDLAG00005022215
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSDLAG00005033496
Gene Symbol: DRD1B
1 Cross references
201 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSDLAG00005012539
Gene Symbol: DRD2A
1 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).